STOCK TITAN

[SCHEDULE 13G/A] INmune Bio Inc. Common stock SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Inmune Bio's Schedule 13G/A shows Praetorian-related entities holding disclosed positions in the company's common stock. Praetorian Capital Fund LLC directly beneficially owns 771,200 shares—comprised of 180,800 shares issuable upon warrants and 590,400 shares underlying call options exercisable within 60 days—representing approximately 2.9% of the class based on 26,585,258 shares outstanding. Mongolia (Barbados) Corp. directly owns 150,000 shares underlying call options (about 0.6%), and Harris Kupperman may be deemed to beneficially own a combined 921,200 shares (about 3.4%).

The filing identifies the reporting persons' roles (investment manager, manager, controlling person) and disclaims beneficial ownership beyond direct holdings. It specifies that reported positions include instruments exercisable within 60 days and includes a certification that the securities were not acquired to change or influence control of the issuer.

La Schedule 13G/A di Inmune Bio indica che entità legate a Praetorian detengono posizioni dichiarate nelle azioni ordinarie della società. Praetorian Capital Fund LLC detiene direttamente la proprietà beneficiaria di 771,200 azioni — composte da 180,800 azioni emesse tramite warrant e 590,400 azioni sottostanti a opzioni call esercitabili entro 60 giorni — rappresentando circa 2.9% della classe sulla base di 26,585,258 azioni in circolazione. Mongolia (Barbados) Corp. detiene direttamente 150,000 azioni sottostanti a opzioni call (circa 0.6%), e Harris Kupperman può essere considerato titolare beneficiario complessivo di 921,200 azioni (circa 3.4%).

La dichiarazione identifica i ruoli delle persone che presentano il rapporto (investment manager, manager, controlling person) e nega possesso beneficiario oltre le partecipazioni dirette. Specifica che le posizioni riportate includono strumenti esercitabili entro 60 giorni e contiene una certificazione che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.

La Schedule 13G/A de Inmune Bio muestra que entidades relacionadas con Praetorian mantienen posiciones declaradas en las acciones ordinarias de la compañía. Praetorian Capital Fund LLC posee directamente la propiedad beneficiaria de 771,200 acciones —compuestas por 180,800 acciones emitibles mediante warrants y 590,400 acciones subyacentes a opciones call ejercitables dentro de 60 días—, lo que representa aproximadamente el 2.9% de la clase sobre la base de 26,585,258 acciones en circulación. Mongolia (Barbados) Corp. posee directamente 150,000 acciones subyacentes a opciones call (unos 0.6%), y Harris Kupperman podría ser considerado beneficiario de un total de 921,200 acciones (unos 3.4%).

La presentación identifica los roles de los informantes (investment manager, manager, controlling person) y niega la propiedad beneficiaria más allá de las participaciones directas. Especifica que las posiciones informadas incluyen instrumentos ejercitables dentro de 60 días e incluye una certificación de que los valores no fueron adquiridos para cambiar o influir en el control del emisor.

Inmune Bio의 Schedule 13G/A는 Praetorian 관련 기관들이 회사 보통주에 대해 신고된 포지션을 보유하고 있음을 보여줍니다. Praetorian Capital Fund LLC는 직접적으로 771,200주의 실질적 소유권을 보유하고 있으며, 이는 워런트로 발행 가능한 180,800주60일 내 행사 가능한 590,400주의 콜옵션으로 구성되어 있어, 발행주식수 26,585,258주를 기준으로 약 2.9%에 해당합니다. Mongolia (Barbados) Corp.는 150,000주의 콜옵션 기초주식을 직접 보유하고 있으며(약 0.6%), Harris Kupperman는 합계 921,200주(약 3.4%)의 실질적 소유자로 간주될 수 있습니다.

신고서는 보고인의 역할(투자 매니저, 매니저, 통제인)을 명시하고 직접 보유분을 넘어선 실질적 소유권을 부인합니다. 또한 보고된 포지션에 60일 내 행사 가능한 증권이 포함되어 있음을 명시하고, 해당 증권이 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득되지 않았다는 인증을 포함하고 있습니다.

Le Schedule 13G/A d'Inmune Bio indique que des entités liées à Praetorian détiennent des positions déclarées sur les actions ordinaires de la société. Praetorian Capital Fund LLC détient directement la propriété bénéficiaire de 771,200 actions — composées de 180,800 actions pouvant être émises via des warrants et de 590,400 actions sous-jacentes à des options d'achat exerçables dans les 60 jours — représentant environ 2.9% de la catégorie sur la base de 26,585,258 actions en circulation. Mongolia (Barbados) Corp. détient directement 150,000 actions sous-jacentes à des options d'achat (environ 0.6%), et Harris Kupperman peut être réputé détenir bénéficiairement au total 921,200 actions (environ 3.4%).

Le dépôt identifie les rôles des personnes déclarantes (investment manager, manager, controlling person) et nie toute propriété bénéficiaire au-delà des avoirs directs. Il précise que les positions déclarées incluent des instruments exerçables dans les 60 jours et comprend une certification que les titres n'ont pas été acquis dans l'intention de modifier ou d'influencer le contrôle de l'émetteur.

Die Schedule 13G/A von Inmune Bio zeigt, dass Praetorian-nahe Einheiten deklarierte Positionen an den Stammaktien des Unternehmens halten. Praetorian Capital Fund LLC besitzt direkt wirtschaftlich 771,200 Aktien — bestehend aus 180,800 Aktien, die durch Warrants ausgebbar sind, und 590,400 Aktien, die zugrunde liegenden Call-Optionen entsprechen, die innerhalb von 60 Tagen ausübbar sind — und entspricht damit rund 2.9% der Aktienklasse auf Basis von 26,585,258 ausstehenden Aktien. Mongolia (Barbados) Corp. besitzt direkt 150,000 Aktien zugrunde liegend an Call-Optionen (etwa 0.6%), und Harris Kupperman kann als wirtschaftlicher Eigentümer von insgesamt 921,200 Aktien (etwa 3.4%) angesehen werden.

Die Meldung nennt die Rollen der meldepflichtigen Personen (Investment Manager, Manager, Controlling Person) und weist ein darüber hinausgehendes wirtschaftliches Eigentum an den Direktbeständen zurück. Sie legt offen, dass die gemeldeten Positionen Instrumente umfassen, die innerhalb von 60 Tagen ausübbar sind, und enthält die Bestätigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Praetorian-related entities disclose a modest passive stake in INMB totaling up to 3.4% via warrants and options.

The filing provides a clear instrument-level breakdown: 771,200 shares for Praetorian Fund, including 180,800 warrants and 590,400 call-option shares, plus 150,000 shares held by Mongolia, measured against a 26,585,258 share base. Reported percentages (Praetorian Fund ~2.9%, Mongolia ~0.6%, combined Kupperman ~3.4%) are below the 5% threshold referenced in the filing, implying limited immediate market impact. The identification of instruments exercisable within 60 days is material for potential dilution and voting exposure if exercised.

TL;DR: Reporting persons characterize positions as non-control and provide standard Schedule 13G disclosure for transparency.

The statement names each reporting entity and their relationships (investment manager, fund manager, controlling shareholder) and expressly disclaims beneficial ownership beyond directly held securities. Item 10 certifies the positions were not acquired to change or influence control. With reported ownership levels (Praetorian Fund ~2.9%, Mongolia ~0.6%, Kupperman combined ~3.4%), the filing aligns with passive investor reporting under Schedule 13G rather than an active control filing.

La Schedule 13G/A di Inmune Bio indica che entità legate a Praetorian detengono posizioni dichiarate nelle azioni ordinarie della società. Praetorian Capital Fund LLC detiene direttamente la proprietà beneficiaria di 771,200 azioni — composte da 180,800 azioni emesse tramite warrant e 590,400 azioni sottostanti a opzioni call esercitabili entro 60 giorni — rappresentando circa 2.9% della classe sulla base di 26,585,258 azioni in circolazione. Mongolia (Barbados) Corp. detiene direttamente 150,000 azioni sottostanti a opzioni call (circa 0.6%), e Harris Kupperman può essere considerato titolare beneficiario complessivo di 921,200 azioni (circa 3.4%).

La dichiarazione identifica i ruoli delle persone che presentano il rapporto (investment manager, manager, controlling person) e nega possesso beneficiario oltre le partecipazioni dirette. Specifica che le posizioni riportate includono strumenti esercitabili entro 60 giorni e contiene una certificazione che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.

La Schedule 13G/A de Inmune Bio muestra que entidades relacionadas con Praetorian mantienen posiciones declaradas en las acciones ordinarias de la compañía. Praetorian Capital Fund LLC posee directamente la propiedad beneficiaria de 771,200 acciones —compuestas por 180,800 acciones emitibles mediante warrants y 590,400 acciones subyacentes a opciones call ejercitables dentro de 60 días—, lo que representa aproximadamente el 2.9% de la clase sobre la base de 26,585,258 acciones en circulación. Mongolia (Barbados) Corp. posee directamente 150,000 acciones subyacentes a opciones call (unos 0.6%), y Harris Kupperman podría ser considerado beneficiario de un total de 921,200 acciones (unos 3.4%).

La presentación identifica los roles de los informantes (investment manager, manager, controlling person) y niega la propiedad beneficiaria más allá de las participaciones directas. Especifica que las posiciones informadas incluyen instrumentos ejercitables dentro de 60 días e incluye una certificación de que los valores no fueron adquiridos para cambiar o influir en el control del emisor.

Inmune Bio의 Schedule 13G/A는 Praetorian 관련 기관들이 회사 보통주에 대해 신고된 포지션을 보유하고 있음을 보여줍니다. Praetorian Capital Fund LLC는 직접적으로 771,200주의 실질적 소유권을 보유하고 있으며, 이는 워런트로 발행 가능한 180,800주60일 내 행사 가능한 590,400주의 콜옵션으로 구성되어 있어, 발행주식수 26,585,258주를 기준으로 약 2.9%에 해당합니다. Mongolia (Barbados) Corp.는 150,000주의 콜옵션 기초주식을 직접 보유하고 있으며(약 0.6%), Harris Kupperman는 합계 921,200주(약 3.4%)의 실질적 소유자로 간주될 수 있습니다.

신고서는 보고인의 역할(투자 매니저, 매니저, 통제인)을 명시하고 직접 보유분을 넘어선 실질적 소유권을 부인합니다. 또한 보고된 포지션에 60일 내 행사 가능한 증권이 포함되어 있음을 명시하고, 해당 증권이 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득되지 않았다는 인증을 포함하고 있습니다.

Le Schedule 13G/A d'Inmune Bio indique que des entités liées à Praetorian détiennent des positions déclarées sur les actions ordinaires de la société. Praetorian Capital Fund LLC détient directement la propriété bénéficiaire de 771,200 actions — composées de 180,800 actions pouvant être émises via des warrants et de 590,400 actions sous-jacentes à des options d'achat exerçables dans les 60 jours — représentant environ 2.9% de la catégorie sur la base de 26,585,258 actions en circulation. Mongolia (Barbados) Corp. détient directement 150,000 actions sous-jacentes à des options d'achat (environ 0.6%), et Harris Kupperman peut être réputé détenir bénéficiairement au total 921,200 actions (environ 3.4%).

Le dépôt identifie les rôles des personnes déclarantes (investment manager, manager, controlling person) et nie toute propriété bénéficiaire au-delà des avoirs directs. Il précise que les positions déclarées incluent des instruments exerçables dans les 60 jours et comprend une certification que les titres n'ont pas été acquis dans l'intention de modifier ou d'influencer le contrôle de l'émetteur.

Die Schedule 13G/A von Inmune Bio zeigt, dass Praetorian-nahe Einheiten deklarierte Positionen an den Stammaktien des Unternehmens halten. Praetorian Capital Fund LLC besitzt direkt wirtschaftlich 771,200 Aktien — bestehend aus 180,800 Aktien, die durch Warrants ausgebbar sind, und 590,400 Aktien, die zugrunde liegenden Call-Optionen entsprechen, die innerhalb von 60 Tagen ausübbar sind — und entspricht damit rund 2.9% der Aktienklasse auf Basis von 26,585,258 ausstehenden Aktien. Mongolia (Barbados) Corp. besitzt direkt 150,000 Aktien zugrunde liegend an Call-Optionen (etwa 0.6%), und Harris Kupperman kann als wirtschaftlicher Eigentümer von insgesamt 921,200 Aktien (etwa 3.4%) angesehen werden.

Die Meldung nennt die Rollen der meldepflichtigen Personen (Investment Manager, Manager, Controlling Person) und weist ein darüber hinausgehendes wirtschaftliches Eigentum an den Direktbeständen zurück. Sie legt offen, dass die gemeldeten Positionen Instrumente umfassen, die innerhalb von 60 Tagen ausübbar sind, und enthält die Bestätigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Praetorian PR LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member
Date:08/14/2025
Praetorian Capital Fund LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member of its Manager
Date:08/14/2025
Praetorian Capital Management LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member
Date:08/14/2025
Mongolia (Barbados) Corp.
Signature:/s/ Genevieve Walkden Jackson
Name/Title:Genevieve Walkden Jackson, Chief Financial Officer of its Controlling Person and Sole Shareholder
Date:08/14/2025
Mongolia Growth Group Ltd.
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, CEO and Executive Chairman
Date:08/14/2025
Kupperman Harris
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman
Date:08/14/2025

FAQ

How many INMB shares does Praetorian Capital Fund LLC beneficially own?

Praetorian Capital Fund LLC beneficially owns 771,200 shares, consisting of 180,800 shares issuable upon warrants and 590,400 shares underlying call options exercisable within 60 days.

What percentage of INMB does Praetorian Fund own?

Praetorian Fund's position represents approximately 2.9% of the outstanding shares based on a 26,585,258 share base disclosed in the filing.

How many INMB shares does Mongolia (Barbados) Corp. hold?

Mongolia (Barbados) Corp. directly beneficially owns 150,000 shares underlying call options, representing about 0.6% of the class.

What is Harris Kupperman's reported beneficial ownership of INMB?

Harris Kupperman may be deemed to beneficially own a combined 921,200 shares (approximately 3.4%), reflecting holdings attributable to Praetorian entities and Mongolia as described in the filing.

Were the INMB securities acquired to influence control of the company?

The filing includes a certification stating the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Inmune Bio Inc

NASDAQ:INMB

INMB Rankings

INMB Latest News

INMB Latest SEC Filings

INMB Stock Data

65.38M
20.01M
24.61%
28.12%
20.29%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOCA RATON